Kinerja vs S&P 500

03
Dilacak Q4 2025–Q2 2026 +13.6%
Total imbal hasil S&P 500 (jendela yang sama) +8.7%
Imbal hasil berlebih +4.9%

Perkiraan portofolio beli-dan-tahan yang dibangun dari snapshot 13F SEC triwulanan. Mengecualikan kas, posisi jual, opsi/derivatif, dan sekuritas non-13(f) — mencerminkan buku ekuitas long yang diungkapkan saja, bukan total AUM dana. Keterlambatan pengajuan SEC hingga 45 hari; ini bukan waktu yang dapat disalin secara real-time.

Cakupan yang dapat dihargai: 99,7% · Opsi dikecualikan: 0,0%

Rincian sektor

04
Healthcare 14,0%
Lainnya/Tidak terpetakan 86,0%

Portofolio lengkap 75 posisi

05
Tipe Rentetan Tren 8 kuartal
XBI SPDR SERIES TRUST $90.202.500 48,01% 570.000 $53.812.223 Naik ×1
SGOV iShares Trust $70.469.000 37,51% 700.000 $7.000
RPRX Royalty Pharma plc - Class A Ordinary Shares $616.770 0,33% 11.000 $89.100
NRIX Nurix Therapeutics, Inc. - Common stock $606.500 0,32% 25.000 $161.650 Turun ×2
INCY Incyte Corporation - Common Stock $600.808 0,32% 5.300 $101.972
ARGX argenx SE - American Depositary Shares $594.701 0,32% 641 $126.611
IRON Disc Medicine, Inc. - Common Stock $585.120 0,31% 8.000 $73.600
RAPP Rapport Therapeutics, Inc. - Common Stock $583.380 0,31% 14.000 $145.320
RARE Ultragenyx Pharmaceutical Inc. - Common Stock $567.630 0,30% 17.000 $104.635 Turun ×1
TRVI Trevi Therapeutics, Inc. - Common Stock $559.500 0,30% 30.000 $201.600
GLUE Monte Rosa Therapeutics, Inc. - Common Stock $556.600 0,30% 23.000 $96.000 Turun ×1
TGTX TG Therapeutics, Inc. - Common Stock $549.400 0,29% 10.000 $117.540 Turun ×2
HALO Halozyme Therapeutics, Inc. - Common Stock $547.890 0,29% 7.000 $29.170 Turun ×1
IONS Ionis Pharmaceuticals, Inc. - Common Stock $539.172 0,29% 6.800 $28.560
PHVS Pharvaris N.V. - Ordinary Shares $518.700 0,28% 15.000 $-46.300 Turun ×2
ARQT Arcutis Biotherapeutics, Inc. - Common stock $516.534 0,27% 19.700 $52.402
AUPH Aurinia Pharmaceuticals Inc - Common Shares $509.100 0,27% 30.000 $64.500
NBIX Neurocrine Biosciences, Inc. - Common Stock $505.605 0,27% 3.000 $-1.331 Turun ×1
IMVT Immunovant, Inc. - Common Stock $500.890 0,27% 13.000 $23.962 Turun ×2
ACAD ACADIA Pharmaceuticals Inc. - Common Stock $500.080 0,27% 19.766 $60.089
PTCT PTC Therapeutics, Inc. - Common Stock $489.420 0,26% 6.000 $80.640
CLDX Celldex Therapeutics, Inc. - Common Stock $483.730 0,26% 13.000 $71.370
IMCR Immunocore Holdings plc - American Depositary Shares $480.727 0,26% 15.141 $24.226
DFTX Definium Therapeutics, Inc. - Common Shares $470.400 0,25% 10.000 $-187.320 Turun ×1
COGT Cogent Biosciences, Inc. - Common Stock $464.400 0,25% 12.000 $2.520
KYMR Kymera Therapeutics, Inc. - Common Stock $458.680 0,24% 4.000 $-66.047 Turun ×2
DYN Dyne Therapeutics, Inc. - Common Stock $444.200 0,24% 20.000 $81.600
ALNY Alnylam Pharmaceuticals, Inc. - Common Stock $441.009 0,23% 1.465 $-43.716
TARS Tarsus Pharmaceuticals, Inc. - Common Stock $440.580 0,23% 7.000 $-50.470
SNDX Syndax Pharmaceuticals, Inc. - Common Stock $437.200 0,23% 20.000 $-30.000
EXEL Exelixis, Inc. - Common Stock $435.280 0,23% 8.000 $-77.170 Turun ×1
CRNX Crinetics Pharmaceuticals, Inc. - Common Stock $411.620 0,22% 11.000 $12.100
NAMS NewAmsterdam Pharma Company N.V. - Ordinary Shares $406.680 0,22% 12.000 $-73.470 Turun ×1
Penerbit tidak dikenal (CUSIP: K08588103) $400.080 0,21% 1.500 Naik ×1
LQDA Liquidia Corporation - Common Stock $398.650 0,21% 5.000
STOK Stoke Therapeutics, Inc. - Common Stock $392.640 0,21% 12.000 $1.920
VKTX Viking Therapeutics, Inc. - Common Stock $390.100 0,21% 10.000 $-98.000 Turun ×1
IMNM Immunome, Inc. - Common Stock $381.420 0,20% 18.000 $-55.980 Turun ×2
PTGX Protagonist Therapeutics, Inc. - Common Stock $367.740 0,20% 3.000 $51.540
HRMY Harmony Biosciences Holdings, Inc. - Common Stock $364.100 0,19% 10.000 $-35.967 Turun ×1
ELVN Enliven Therapeutics, Inc. - Common Stock $355.250 0,19% 7.000 $80.850
SYRE Spyre Therapeutics, Inc. - Common Stock $355.120 0,19% 4.000 $94.900 Turun ×2
NTLA Intellia Therapeutics, Inc. - Common Stock $338.400 0,18% 20.000 $-6.458 Turun ×1
MDGL Madrigal Pharmaceuticals, Inc. - Common Stock $322.170 0,17% 600 $8.088
KNSA Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares $319.750 0,17% 5.000 $-113.600 Turun ×2
ALKS Alkermes plc - Ordinary Shares $314.370 0,17% 6.000 $102.210
TNGX Tango Therapeutics, Inc. - Common Stock $312.600 0,17% 10.000 $11.352 Turun ×1
ARDX Ardelyx, Inc. - Common Stock $306.000 0,16% 60.000 $-173.200 Turun ×1
VERA Vera Therapeutics, Inc. - Class A Common Stock $300.370 0,16% 7.000 $-101.930 Turun ×1
MIRM Mirum Pharmaceuticals, Inc. - common stock $292.675 0,16% 2.500 $-169.225 Turun ×2
ORKA Oruka Therapeutics, Inc. - Common Stock $285.510 0,15% 3.000 $41.830 Turun ×1
SUPN Supernus Pharmaceuticals, Inc. - Common Stock $279.060 0,15% 6.000 $-31.080
CRSP CRISPR Therapeutics AG - Common Shares $272.700 0,15% 5.000 $-179.215 Turun ×2
ZYME Zymeworks Inc. - Common Stock $261.400 0,14% 10.000 $11.000
KRYS Krystal Biotech, Inc. - Common Stock $257.196 0,14% 692 Naik ×1
CMPS COMPASS Pathways Plc - American Depository Shares $254.700 0,14% 18.000 $-137.930 Turun ×1
XENE Xenon Pharmaceuticals Inc. - Common Shares $253.512 0,13% 4.200 $9.282
AXSM Axsome Therapeutics, Inc. - Common Stock $244.770 0,13% 1.000 $-236.092 Turun ×1
AVBP ArriVent BioPharma, Inc. - Common Stock $244.604 0,13% 7.041 Naik ×1
DNTH Dianthus Therapeutics, Inc. - Common Stock $243.700 0,13% 2.500 $-175.900 Turun ×2
JAZZ Jazz Pharmaceuticals plc - Ordinary Shares $233.982 0,12% 971
KOD Kodiak Sciences Inc - Common Stock $233.760 0,12% 6.000 $-147.440 Turun ×2
RVMD Revolution Medicines, Inc. - Common Stock $224.736 0,12% 1.200
BBIO BridgeBio Pharma, Inc. - Common Stock $223.440 0,12% 3.000 $-222.120 Turun ×2
RYTM Rhythm Pharmaceuticals, Inc. - Common Stock $222.060 0,12% 2.000
DNLI Denali Therapeutics Inc. - Common Stock $217.668 0,12% 8.463
ARWR Arrowhead Pharmaceuticals, Inc. - Common Stock $211.926 0,11% 2.600
SRRK Scholar Rock Holding Corporation - Common Stock $210.485 0,11% 3.827 Naik ×1
EWTX Edgewise Therapeutics, Inc. - Common Stock $203.150 0,11% 5.000 $-1.600 Turun ×1
AMLX Amylyx Pharmaceuticals, Inc. - Common Stock $194.650 0,10% 10.838 $44.002
CTMX CytomX Therapeutics, Inc. - Common Stock $147.750 0,08% 39.400 Naik ×1
OCUL Ocular Therapeutix, Inc. - Common Stock $147.300 0,08% 15.000 $20.250
EYPT EyePoint, Inc. - Common Stock $143.000 0,08% 10.000 $14.100
ORIC Oric Pharmaceuticals, Inc. - Common Stock $140.790 0,07% 13.000 $-23.920
OLMA Olema Pharmaceuticals, Inc. - Common Stock $125.100 0,07% 10.000 $-24.000

Taruhan baru terbesar

09

Posisi baru dibuka kuartal ini, terbesar diurutkan pertama.

SekuritasNilaiSaham% dari portofolio
Penerbit tidak dikenal (CUSIP: K08588103) $400.080 1.500 0,21%
LQDA $398.650 5.000 0,21%
KRYS $257.196 692 0,14%
AVBP $244.604 7.041 0,13%
JAZZ $233.982 971 0,12%
RVMD $224.736 1.200 0,12%
RYTM $222.060 2.000 0,12%
DNLI $217.668 8.463 0,12%
ARWR $211.926 2.600 0,11%
SRRK $210.485 3.827 0,11%
CTMX $147.750 39.400 0,08%

Penggerak teratas (QoQ)

10
SekuritasAksiSaham ΔNilai Δ
XBI Beli lebih banyak +285K +$53.8M
AXSM Dipangkas -2K -$236K
BBIO Dipangkas -3K -$222K
TRVI Hanya pergerakan harga +0 +$202K
DFTX Dipangkas -25K -$187K
CRSP Dipangkas -4K -$179K
DNTH Dipangkas -2K -$176K
ARDX Dipangkas -20K -$173K
MIRM Dipangkas -2K -$169K
NRIX Dipangkas -4K +$162K

Posisi yang keluar

11

Termasuk peristiwa perusahaan (merger, delisting) — tidak semua keluar adalah penjualan

Posisi tertutup mencerminkan perubahan pelaporan 13F; bagi manajer indeks, ini sering kali mekanis (penghapusan pencatatan, M&A, penyeimbangan ulang indeks), bukan keputusan aktif.

SekuritasKuartalSaham sebelumnyaNilai sebelumnyaHarga sejak keluar
SERA 30 Juni 2026 2.396.685 $4.865.271 14,8%
TYRA 30 Juni 2026 16.000 $612.800 -36,0%
TVTX 31 Maret 2026 15.272 $583.543 91,6%
ASND 30 Juni 2026 2.500 $571.825 -14,6%
JAZZ 31 Maret 2026 3.258 $553.860 24,7%
CGON 31 Maret 2026 13.293 $551.925 -0,4%
BLTE 31 Maret 2026 3.443 $550.742 0,1%
APLS 31 Maret 2026 21.866 $549.274 Tidak lagi dilacak
TERN 31 Maret 2026 13.560 $547.824 Tidak lagi dilacak
RVMD 31 Maret 2026 6.872 $547.355 112,5%
CNTA 31 Maret 2026 21.879 $547.194 Tidak lagi dilacak
CYTK 30 Juni 2026 8.300 $547.053 -23,0%
MLYS 31 Maret 2026 14.818 $537.745 -12,8%
ACLX 31 Maret 2026 8.224 $536.205 Tidak lagi dilacak
ROIV 31 Maret 2026 24.621 $534.276 29,0%
LQDA 31 Maret 2026 15.485 $534.078 -24,1%
PVLA 31 Maret 2026 5.084 $532.142 6,3%
INSM 31 Maret 2026 3.049 $530.648 -32,0%
NUVL 31 Maret 2026 5.261 $529.204 Tidak lagi dilacak
VRDN 31 Maret 2026 16.967 $528.013 -0,8%
WVE 31 Maret 2026 31.040 $527.680 -47,9%
MAZE 31 Maret 2026 12.672 $525.001 -11,5%
DNLI 31 Maret 2026 31.762 $524.391 4,2%
BMRN 31 Maret 2026 8.772 $521.320 1,2%
BEAM 31 Maret 2026 18.334 $508.218 2,8%
AGIO 30 Juni 2026 15.000 $507.450 -14,3%
RYTM 31 Maret 2026 4.738 $507.156 6,7%
PRAX 30 Juni 2026 1.500 $483.285 -11,7%
UPB 31 Maret 2026 17.634 $478.763 -44,0%
GPCR 31 Maret 2026 6.719 $467.306 -42,6%
MNMD 31 Maret 2026 34.841 $466.521 Tidak lagi dilacak
INBX 30 Juni 2026 6.927 $465.702 2,4%
ARWR 31 Maret 2026 6.689 $444.083 2,4%
ALMS 31 Maret 2026 43.769 $427.185 -68,9%
ERAS 30 Juni 2026 17.327 $280.351 -19,5%
CELC 30 Juni 2026 2.000 $228.280 -31,1%
KALV 30 Juni 2026 10.795 $217.303 Tidak lagi dilacak
LEGN 30 Juni 2026 12.000 $217.080 -35,7%
APGE 30 Juni 2026 2.500 $210.425 Tidak lagi dilacak
UTHR 30 Juni 2026 350 $207.543 0,0%
SMMT 30 Juni 2026 10.223 $193.828 15,0%
CMPX 30 Juni 2026 30.000 $158.700 -60,9%